ISSN 0976 - 8157

pharmacie-globale.info

Indexing & Abstracting: DOAJ, Index Copernicus, Chemical Abstract Services (CAS), EBSCO Publishing, Ulrich's Serial database, NewJour, GFMER, Science Central, Libraries Directory, IRNEM, Biblioteca, Open J-gate...........
Home News

FDA grants orphan drug status to RiVax

The US Food and Drug Administration (FDA)has given orphan drug status to Soligenix's ricin intoxication preventive, RiVax. Soligenix has completed a Phase 1A clinical trial of RiVax which showed that the immunogen was safe and induced antibodies anticipated to protect humans from ricin exposure. Further, the company is continuing Phase 1B trial of RiVax. Soligenix president and CEO Christopher Schaber said the FDA's decision to grant RiVax orphan drug designation for the prevention of ricin intoxication marks another important step forward in their biodefense pipeline.

"Marketing exclusivity through orphan drug designation adds significantly to the existing patent estate surrounding RiVax," Schaber said.

(pharmaceutical-business-review.com)

.
 

LATEST NEWS


Editorial Board

  • Professor Lilian M. Azzopardi
    Department of Pharmacy,
    University of Malta,
    Malta

    Professor Karim A. Alkadhi
    Department of Pharmacological and Pharmaceutical Sciences,
    University of Houston,
    Houston, USA

    Dr. Poonam Singh
    Scientist, Division of Toxicology,
    Central Drug Research Institute,
    India

    Dr. Jason Eriksen
    Department of Pharmacological and Pharmaceutical Sciences,
    University of Houston,
    Houston, USA

    Professor V. Kusum Devi
    Department of Pharmaceutics,
    Al-Ameen College of Pharmacy,
    Bangalore, India

    Associate Professor Bruce Charles
    Pharmacy Australia Centre of Excellence,
    School of Pharmacy, The University of Queensland,
    Brisbane, Australia

    Dr. Karem Alzoubi
    Assistant Dean, Faculty of Pharmacy,
    Jordan University of Science and Technology,
    Jordan

    Professor Nurten Ă–zdemir
    Faculty of Pharmacy, Ankara University,
    Ankara, Turkey

    Dr. Veena S. Nukoolkarn
    Department of Pharmacognosy,
    Faculty of Pharmacy, Mahidol University,
    Phyathai, Bangkok

    Dr. Ajay Sharma
    Mason Eye Institute,
    University of Missouri,
    Columbia,
    MO, United States

    Professor Olobayo O Kunle
    Director, Department of Pharmaceutical Technology and Raw Material Development,
    National Institute of Pharmaceutical Research and Development (NIPRD),
    Idu, Abuja, Nigeria

    Okoro Roland Nnaemeka
    Department of Clinical Pharmacy and Pharmacy Administration,
    University of Maiduguri,
    Maiduguri, Borno State, Nigeria

    Dr. Manoj Sharma
    Principal, Shri R N S College of Pharmacy,
    Gormi, Bhind, Madhya Pradesh, India

    Professor Dhrubo Jyoti Sen
    Department of Pharmaceutical Chemistry,
    Shri Sarvajanik Pharmacy
    College,
    Mehsana, Gujarat, India

    .

Who's Online

We have 10 guests and 1 member online

Statistics Counter

joomla visitor

Polls

Do you think pharmaceutical companies should spend more on educating physicians about their products?
 

Social Widgets